Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3-MYC Interactions as a Target in Pancreatic Cancer.
about
Targeted delivery of chemotherapy using HSP90 inhibitor drug conjugates is highly active against pancreatic cancer models.Conditionally reprogrammed normal and primary tumor prostate epithelial cells: a novel patient-derived cell model for studies of human prostate cancer.Genomic comparison of early-passage conditionally reprogrammed breast cancer cells to their corresponding primary tumors.Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens.Expanding primary cells from mucoepidermoid and other salivary gland neoplasms for genetic and chemosensitivity testing.
P2860
Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3-MYC Interactions as a Target in Pancreatic Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Screening of Conditionally Rep ...... a Target in Pancreatic Cancer.
@en
Screening of Conditionally Rep ...... a Target in Pancreatic Cancer.
@nl
type
label
Screening of Conditionally Rep ...... a Target in Pancreatic Cancer.
@en
Screening of Conditionally Rep ...... a Target in Pancreatic Cancer.
@nl
prefLabel
Screening of Conditionally Rep ...... a Target in Pancreatic Cancer.
@en
Screening of Conditionally Rep ...... a Target in Pancreatic Cancer.
@nl
P2093
P2860
P1476
Screening of Conditionally Rep ...... a Target in Pancreatic Cancer.
@en
P2093
Diana Behrens
Diana Restifo
Egor Bobrov
Elena Lysenko
Erica A Golemis
Eugenia Banina
Grigorii Andrianov
Igor Astsaturov
Ilya G Serebriiskii
John P Hoffman
P2860
P304
P356
10.1158/1078-0432.CCR-16-0149
P407
P577
2016-07-06T00:00:00Z